Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP284361.RApEz92CDZyONjSxPLNEL5t7fECVcqZ_dKdWTBbRt4_og130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP284361.RApEz92CDZyONjSxPLNEL5t7fECVcqZ_dKdWTBbRt4_og130_assertion type Assertion NP284361.RApEz92CDZyONjSxPLNEL5t7fECVcqZ_dKdWTBbRt4_og130_head.
- NP284361.RApEz92CDZyONjSxPLNEL5t7fECVcqZ_dKdWTBbRt4_og130_assertion description "[Any drug including anti-TNF ? blocker which can downregulate the TCR, infiltrated neutrophils, or CD163+ macrophages in the synovial tissue is the rationale for the management of SpA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP284361.RApEz92CDZyONjSxPLNEL5t7fECVcqZ_dKdWTBbRt4_og130_provenance.
- NP284361.RApEz92CDZyONjSxPLNEL5t7fECVcqZ_dKdWTBbRt4_og130_assertion evidence source_evidence_literature NP284361.RApEz92CDZyONjSxPLNEL5t7fECVcqZ_dKdWTBbRt4_og130_provenance.
- NP284361.RApEz92CDZyONjSxPLNEL5t7fECVcqZ_dKdWTBbRt4_og130_assertion SIO_000772 23840241 NP284361.RApEz92CDZyONjSxPLNEL5t7fECVcqZ_dKdWTBbRt4_og130_provenance.
- NP284361.RApEz92CDZyONjSxPLNEL5t7fECVcqZ_dKdWTBbRt4_og130_assertion wasDerivedFrom befree-20140225 NP284361.RApEz92CDZyONjSxPLNEL5t7fECVcqZ_dKdWTBbRt4_og130_provenance.
- NP284361.RApEz92CDZyONjSxPLNEL5t7fECVcqZ_dKdWTBbRt4_og130_assertion wasGeneratedBy ECO_0000203 NP284361.RApEz92CDZyONjSxPLNEL5t7fECVcqZ_dKdWTBbRt4_og130_provenance.